Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated:  8/29/2017
Novartis Investigative Site
mi
from
Columbus, OH
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Novartis Investigative Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated:  8/29/2017
Novartis Investigative Site
mi
from
Knoxville, TN
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Novartis Investigative Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated:  8/29/2017
Novartis Investigative Site
mi
from
Richmond, VA
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Novartis Investigative Site
mi
from
Richmond, VA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated:  8/29/2017
Novartis Investigative Site
mi
from
Phoenix, AZ
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Novartis Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated:  8/29/2017
Novartis Investigative Site
mi
from
Hamburg,
Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability and Effects on Arterial Structure and Function of ACZ885 in Patients With Intermittent Claudication.
Status: Enrolling
Updated: 8/29/2017
Novartis Investigative Site
mi
from
Hamburg,
Click here to add this to my saved trials
Coronary Artery Vasculopathy in Pediatric Heart Transplant Patients
Early Detection of Coronary Artery Vasculopathy in Pediatric Heart Transplant Patients: A Prospective Assessment Using Coronary Flow Reserve and Contrast-Enhanced Cardiac MRI
Status: Enrolling
Updated:  8/29/2017
University of Michigan Congenital Heart Center
mi
from
Ann Arbor, MI
Coronary Artery Vasculopathy in Pediatric Heart Transplant Patients
Early Detection of Coronary Artery Vasculopathy in Pediatric Heart Transplant Patients: A Prospective Assessment Using Coronary Flow Reserve and Contrast-Enhanced Cardiac MRI
Status: Enrolling
Updated: 8/29/2017
University of Michigan Congenital Heart Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
An Intervention to Improve Function in Severe Cardiopulmonary Illness
An Intervention to Enhance Function in Severe Cardiopulmonary Illness
Status: Enrolling
Updated:  8/30/2017
VA Puget Sound Health Care System
mi
from
Seattle, WA
An Intervention to Improve Function in Severe Cardiopulmonary Illness
An Intervention to Enhance Function in Severe Cardiopulmonary Illness
Status: Enrolling
Updated: 8/30/2017
VA Puget Sound Health Care System
mi
from
Seattle, WA
Click here to add this to my saved trials
The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment
The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment
Status: Enrolling
Updated:  8/30/2017
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment
The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment
Status: Enrolling
Updated: 8/30/2017
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant
Optical Coherence Tomography to Evaluate Cardiac Allograft Vasculopathy in Patients Undergoing Clinically Indicated Angiographies Post Heart Transplant
Status: Enrolling
Updated:  8/30/2017
Columbia University Medical Center
mi
from
New York, NY
Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant
Optical Coherence Tomography to Evaluate Cardiac Allograft Vasculopathy in Patients Undergoing Clinically Indicated Angiographies Post Heart Transplant
Status: Enrolling
Updated: 8/30/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients
Effects of Angiotensin Converting Enzyme Inhibitors on Total Hip and Knee Arthroplasty Patients
Status: Enrolling
Updated:  8/30/2017
Duke University
mi
from
Durham, NC
ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients
Effects of Angiotensin Converting Enzyme Inhibitors on Total Hip and Knee Arthroplasty Patients
Status: Enrolling
Updated: 8/30/2017
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF
Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF
Status: Enrolling
Updated:  8/30/2017
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF
Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF
Status: Enrolling
Updated: 8/30/2017
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated:  9/7/2017
Dermatology Cosmetic Laser Medical Associates of La Jolla, Inc.
mi
from
San Diego, CA
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated: 9/7/2017
Dermatology Cosmetic Laser Medical Associates of La Jolla, Inc.
mi
from
San Diego, CA
Click here to add this to my saved trials
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated:  9/7/2017
ATS Clinical Research
mi
from
Santa Monica, CA
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated: 9/7/2017
ATS Clinical Research
mi
from
Santa Monica, CA
Click here to add this to my saved trials
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated:  9/7/2017
Dermatology Research Institute
mi
from
Coral Gables, FL
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated: 9/7/2017
Dermatology Research Institute
mi
from
Coral Gables, FL
Click here to add this to my saved trials
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated:  9/7/2017
Kenneth Beer MD, PA
mi
from
West Palm Beach, FL
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated: 9/7/2017
Kenneth Beer MD, PA
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated:  9/7/2017
Mercy Health Research
mi
from
Washington, MO
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated: 9/7/2017
Mercy Health Research
mi
from
Washington, MO
Click here to add this to my saved trials
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated:  9/7/2017
Sadick Research Group
mi
from
New York, NY
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated: 9/7/2017
Sadick Research Group
mi
from
New York, NY
Click here to add this to my saved trials
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated:  9/7/2017
Stony Brook University Medical Center
mi
from
Stony Brook, NY
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated: 9/7/2017
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated:  9/7/2017
Tennessee Clinical Research Center
mi
from
Nashville, TN
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated: 9/7/2017
Tennessee Clinical Research Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated:  9/7/2017
Charlottesville Dermatology
mi
from
Charlottesville, VA
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated: 9/7/2017
Charlottesville Dermatology
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated:  9/7/2017
Premier Clinical Research
mi
from
Spokane, WA
A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
A Phase 2, Double-blind and Placebo Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated: 9/7/2017
Premier Clinical Research
mi
from
Spokane, WA
Click here to add this to my saved trials
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively
Status: Enrolling
Updated:  9/8/2017
Retina Consultants of Hawaii
mi
from
'Aiea, HI
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively
Status: Enrolling
Updated: 9/8/2017
Retina Consultants of Hawaii
mi
from
'Aiea, HI
Click here to add this to my saved trials
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively
Status: Enrolling
Updated:  9/8/2017
The Retina Center at Pali Momi
mi
from
'Aiea, HI
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively
Status: Enrolling
Updated: 9/8/2017
The Retina Center at Pali Momi
mi
from
'Aiea, HI
Click here to add this to my saved trials
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively
Status: Enrolling
Updated:  9/8/2017
Retina Consultants of Hawaii, Inc
mi
from
Honolulu, HI
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively
Status: Enrolling
Updated: 9/8/2017
Retina Consultants of Hawaii, Inc
mi
from
Honolulu, HI
Click here to add this to my saved trials
The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study)
A Phase II, Randomized, Blinded, Study of the Safety and Efficacy of Transendocardial Injection of Allogeneic Human Mesenchymal Stem Cells (hMSCs) (20 Million or 100 Million Total MSCs) in Patients With Chronic Ischemic Left Ventricular Dysfunction Secondary to Myocardial Infarction.
Status: Enrolling
Updated:  9/13/2017
ISCI / University of Miami
mi
from
Miami, FL
The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study)
A Phase II, Randomized, Blinded, Study of the Safety and Efficacy of Transendocardial Injection of Allogeneic Human Mesenchymal Stem Cells (hMSCs) (20 Million or 100 Million Total MSCs) in Patients With Chronic Ischemic Left Ventricular Dysfunction Secondary to Myocardial Infarction.
Status: Enrolling
Updated: 9/13/2017
ISCI / University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Spinal Anesthesia Induced Hypotension During Cesarean Section
Comparison of Phenylephrine Infusion With Colloids vs. Crystalloids for Reduction of Spinal-induced Hypotension During Cesarean Section
Status: Enrolling
Updated:  9/14/2017
PennState Hershey Milton S. Hershey Medical Center
mi
from
Hershey, PA
Spinal Anesthesia Induced Hypotension During Cesarean Section
Comparison of Phenylephrine Infusion With Colloids vs. Crystalloids for Reduction of Spinal-induced Hypotension During Cesarean Section
Status: Enrolling
Updated: 9/14/2017
PennState Hershey Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs
Effect of Polidocanol Endovenous Microfoam (PEM) Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in Venous Leg Ulcers (VLUs)
Status: Enrolling
Updated:  9/14/2017
OhioHealth Riverside Methodist Hospital
mi
from
Columbus, OH
Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs
Effect of Polidocanol Endovenous Microfoam (PEM) Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in Venous Leg Ulcers (VLUs)
Status: Enrolling
Updated: 9/14/2017
OhioHealth Riverside Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated:  9/14/2017
Baptist Clinical Research
mi
from
Pensacola, FL
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated: 9/14/2017
Baptist Clinical Research
mi
from
Pensacola, FL
Click here to add this to my saved trials
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated:  9/14/2017
The Care Group, LLC
mi
from
Indianapolis, IN
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated: 9/14/2017
The Care Group, LLC
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated:  9/14/2017
Boston Med Ctr
mi
from
Boston, MA
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated: 9/14/2017
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated:  9/14/2017
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated: 9/14/2017
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Effect of Right Ventricular Lead Position on Defibrillation Threshold
Effect of Right Ventricular Lead Position on Defibrillation Threshold
Status: Enrolling
Updated:  9/18/2017
OhioHealth Grant Medical Center
mi
from
Columbus, OH
Effect of Right Ventricular Lead Position on Defibrillation Threshold
Effect of Right Ventricular Lead Position on Defibrillation Threshold
Status: Enrolling
Updated: 9/18/2017
OhioHealth Grant Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures
Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures
Status: Enrolling
Updated:  9/20/2017
James Whitcomb Riley Hospital for Children
mi
from
Indianapolis, IN
Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures
Incidence of Venous Thromboembolism in Children Undergoing Elective Neurosurgical Procedures
Status: Enrolling
Updated: 9/20/2017
James Whitcomb Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Comparison of Magnetic Resonance Imaging in Persons With Heart Failure to Health, Aged Matched Controls
A Comparison of Magnetic Resonance Imaging in Persons With Heart Failure to Health, Aged Matched Controls (MIND-HF)
Status: Enrolling
Updated:  9/20/2017
Emory University Hospital Midtown
mi
from
Atlanta, GA
A Comparison of Magnetic Resonance Imaging in Persons With Heart Failure to Health, Aged Matched Controls
A Comparison of Magnetic Resonance Imaging in Persons With Heart Failure to Health, Aged Matched Controls (MIND-HF)
Status: Enrolling
Updated: 9/20/2017
Emory University Hospital Midtown
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Comparison of Magnetic Resonance Imaging in Persons With Heart Failure to Health, Aged Matched Controls
A Comparison of Magnetic Resonance Imaging in Persons With Heart Failure to Health, Aged Matched Controls (MIND-HF)
Status: Enrolling
Updated:  9/20/2017
The Emory Clinic
mi
from
Atlanta, GA
A Comparison of Magnetic Resonance Imaging in Persons With Heart Failure to Health, Aged Matched Controls
A Comparison of Magnetic Resonance Imaging in Persons With Heart Failure to Health, Aged Matched Controls (MIND-HF)
Status: Enrolling
Updated: 9/20/2017
The Emory Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Comparison of Magnetic Resonance Imaging in Persons With Heart Failure to Health, Aged Matched Controls
A Comparison of Magnetic Resonance Imaging in Persons With Heart Failure to Health, Aged Matched Controls (MIND-HF)
Status: Enrolling
Updated:  9/20/2017
Emory St. Joseph's Hospital
mi
from
Atlanta, GA
A Comparison of Magnetic Resonance Imaging in Persons With Heart Failure to Health, Aged Matched Controls
A Comparison of Magnetic Resonance Imaging in Persons With Heart Failure to Health, Aged Matched Controls (MIND-HF)
Status: Enrolling
Updated: 9/20/2017
Emory St. Joseph's Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Palo Alto, CA
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Palo Alto, CA
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Vista, CA
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Vista, CA
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Clearwater, FL
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Sarasota, FL
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Sarasota, FL
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Chicago, IL
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Indianapolis, IN
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Boone, NC
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Boone, NC
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Durham, NC
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Durham, NC
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Toledo, OH
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Toledo, OH
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Philadelphia, PA
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
San Antonio, TX
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated:  9/20/2017
GSK Investigational Site
mi
from
Norfolk, VA
3 Month PHI PAD PoM Study
A Multi-center, Placebo-controlled Study to Evaluate the Safety and Efficacy of GSK1278863 vs. Placebo in Subjects With Peripheral Artery Disease (PAD).
Status: Enrolling
Updated: 9/20/2017
GSK Investigational Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Improving Heart Failure Outcomes Rural
Improving Heart Failure Outcomes (IHO)
Status: Enrolling
Updated:  9/22/2017
Riverside Shore Memorial Hospital
mi
from
Nassawadox, VA
Improving Heart Failure Outcomes Rural
Improving Heart Failure Outcomes (IHO)
Status: Enrolling
Updated: 9/22/2017
Riverside Shore Memorial Hospital
mi
from
Nassawadox, VA
Click here to add this to my saved trials
Improving Heart Failure Outcomes Rural
Improving Heart Failure Outcomes (IHO)
Status: Enrolling
Updated:  9/22/2017
Riverside Tappahannock Hospital
mi
from
Tappahannock, VA
Improving Heart Failure Outcomes Rural
Improving Heart Failure Outcomes (IHO)
Status: Enrolling
Updated: 9/22/2017
Riverside Tappahannock Hospital
mi
from
Tappahannock, VA
Click here to add this to my saved trials